Carotenuto, Pietro
 Distribuzione geografica
Continente #
AS - Asia 2.108
NA - Nord America 1.603
EU - Europa 1.407
SA - Sud America 239
AF - Africa 49
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.411
Nazione #
US - Stati Uniti d'America 1.540
SG - Singapore 923
RU - Federazione Russa 626
IT - Italia 429
CN - Cina 401
VN - Vietnam 328
BR - Brasile 199
HK - Hong Kong 181
DE - Germania 71
NL - Olanda 59
FR - Francia 55
IN - India 54
JP - Giappone 48
BD - Bangladesh 37
FI - Finlandia 33
CA - Canada 32
GB - Regno Unito 31
SE - Svezia 28
KR - Corea 26
UA - Ucraina 22
ID - Indonesia 17
MX - Messico 17
IQ - Iraq 16
PK - Pakistan 15
AR - Argentina 14
CI - Costa d'Avorio 14
ZA - Sudafrica 11
ES - Italia 9
IE - Irlanda 9
TH - Thailandia 9
TR - Turchia 9
EC - Ecuador 8
KE - Kenya 8
PH - Filippine 8
PL - Polonia 8
AT - Austria 7
IR - Iran 7
DO - Repubblica Dominicana 5
PY - Paraguay 5
JO - Giordania 4
PE - Perù 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CL - Cile 3
CO - Colombia 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AU - Australia 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
LT - Lituania 2
MW - Malawi 2
PT - Portogallo 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GF - Guiana Francese 1
GN - Guinea 1
GT - Guatemala 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SD - Sudan 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UG - Uganda 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.411
Città #
Singapore 489
San Jose 307
Hong Kong 174
Ashburn 162
Moscow 148
Naples 148
Hefei 120
Beijing 103
Santa Clara 101
Chandler 100
Ho Chi Minh City 78
Hanoi 73
The Dalles 62
Los Angeles 55
Amsterdam 48
Tokyo 40
Lauterbourg 38
Millbury 32
Rome 24
New York 23
Redondo Beach 23
Council Bluffs 22
Kochi 22
Lawrence 22
Orta di Atella 22
Seoul 21
Buffalo 18
Helsinki 18
Dallas 17
Orem 17
Haiphong 16
Munich 16
Jacksonville 15
Chicago 14
Falkenstein 14
Milan 14
Frankfurt am Main 13
Rio de Janeiro 13
Da Nang 12
Dong Ket 12
Montreal 12
Seattle 12
São Paulo 12
Woodbridge 12
Houston 11
Napoli 11
Wilmington 11
Denver 10
Brooklyn 9
London 9
Nuremberg 9
Toronto 9
Baghdad 8
Mexico City 8
San Francisco 8
Turin 8
Belo Horizonte 7
Biên Hòa 7
Guangzhou 7
Hải Dương 7
Chennai 6
Dublin 6
Nairobi 6
Pune 6
Turku 6
Warsaw 6
Washington 6
Boston 5
Des Moines 5
Lappeenranta 5
Phoenix 5
Salerno 5
Thái Nguyên 5
Amman 4
Atlanta 4
Bangkok 4
Boardman 4
Dhaka 4
Ercolano 4
Manchester 4
Philadelphia 4
Quito 4
Quận Ba 4
Santo André 4
Shanghai 4
Stockholm 4
Tashkent 4
Venice 4
Almería 3
Bari 3
Bengaluru 3
Bình Dương 3
Campinas 3
Can Tho 3
Fairfield 3
Franca 3
Grand Rapids 3
Hưng Yên 3
Jakarta 3
Joinville 3
Totale 3.021
Nome #
Integrated genomics identifies MiR-181/TFAM pathway as a critical driver of drug resistance in melanoma 213
Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. 197
Thyroid Cancer and Fibroblasts 182
Combination therapy with β-carotene+5-FU to overcome uL3-mediated drug resistance in p53 deleted colon cancer cells 163
Targeting SLC7A11/xCT counteracts uL3mediated colorectal cancer drug resistance in 2D cell culture model and in ovo CAM xenograft 160
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 148
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 147
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma 145
Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells 143
Role of uL3 in the crosstalk between nucleolar stress and autophagy in colon cancer cells 142
uL3 loss sensitize resistant p53 deleted colon cancer cells to ferroptosis 140
β-carotene plus 5-FU: a promising strategy to fight uL3-mediated drug resistance in colorectal cancer cells 139
PRUNE and NM23-M1 expression in Embryonic and Adult Mouse Brain. 137
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 137
uL3 status influences ferroptotic cell death in p53-deleted colorectal cancer cells 132
Therapeutic Approaches Targeting Nucleolus in Cancer. 129
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress 129
uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells 124
Pemiganitib. Fibroblast growth factor receptor inhibitor, Treatment of cholangiocarcinoma. 124
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 124
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 123
A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation 123
Novel therapeutic strategy combining β-carotene with 5-FU to overcome uL3-mediated chemoresistance in colorectal cancer cells 122
Optimizing response to gefitinib in the treatment of non-small-cell lung cancer 122
The pervasive role of the MiR-181 family in development, neurodegeneration, and cancer 119
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis 112
Ribosomal protein uL3 is involved in translational reprogramming of 5-FU resistant colorectal cancer cells 109
Characterisation of the immune-related transcriptome in resected biliary tract cancers 108
JTESS (Telencephalic Embryonic Subtractive Sequences): a Unique Collection of Neurodevelopmental Genes. 105
Histone Deacetylase SIRT1 promotes loss of primary cilia in Cholangiocarcinoma 104
The evolving role of fgfr2 inhibitors in intrahepatic cholangiocarcinoma: From molecular biology to clinical targeting 104
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study 99
Role of uL3 in the translational reprogramming of 5-FU resistant colorectal cancer cells lacking functional p53 98
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 97
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma 94
New therapeutic strategies for drug-resistant melanoma 91
Spatial and temporal expressions of prune reveal a role in Müller gliogenesis during Xenopus retinal development 89
Noncoding RNAs as novel biomarkers in pancreatic cancer: What do we know? 89
Novel uL3-based Therapeutic Approaches to Treat Colon Cancer Devoid of p53 85
Vandetanib: An overview of its clinical development in NSCLC and other tumors 79
Ribosomal protein uL3 as regulator of ferroptosis in 5-FU resistance 77
Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay 76
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy 64
Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach 63
Prognostic applications of gene expression signatures in breast cancer 56
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth 55
Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies 50
Triple negative breast cancer: From molecular portrait to therapeutic intervention 44
Totale 5.512
Categoria #
all - tutte 16.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022118 4 4 0 2 0 2 0 5 26 21 9 45
2022/2023337 25 8 8 9 45 49 5 38 58 49 32 11
2023/2024319 14 39 51 15 18 41 12 30 7 10 63 19
2024/20251.588 50 39 8 100 64 152 165 122 78 168 534 108
2025/20262.967 288 290 289 285 496 115 420 176 312 143 118 35
Totale 5.512